Similar articles

• Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.

  [No authors listed] [No authors listed] Harv Womens Health Watch. 2002 Oct;10(2):2-4. Harv Womens Health Watch. 2002. PMID: 12393317 No abstract available.
• ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.

  American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. Obstet Gynecol. 2008 Nov;112(5):1189-92. doi: 10.1097/AOG.0b013e31818e8782. Obstet Gynecol. 2008. PMID: 18978127
• Hormone therapy use and outcomes in the Women's Health Initiative trials.

  Roehm E. Roehm E. JAMA. 2014 Jan 22-29;311(4):417. doi: 10.1001/jama.2013.285154. JAMA. 2014. PMID: 24449322 No abstract available.
• New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

  Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT. Modena MG, et al. Maturitas. 2005 Sep 16;52(1):1-10. doi: 10.1016/j.maturitas.2005.05.003. Maturitas. 2005. PMID: 15963666 Review.
• Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.

  van der Mooren MJ, Kenemans P. van der Mooren MJ, et al. Eur J Obstet Gynecol Reprod Biol. 2003 Apr 25;107(2):123-4. doi: 10.1016/s0301-2115(02)00413-x. Eur J Obstet Gynecol Reprod Biol. 2003. PMID: 12648855 Review. No abstract available.